Skip to main content
. 2010 Dec 17;4(4):537–542. doi: 10.5009/gnl.2010.4.4.537

Fig. 1.

Fig. 1

Distribution of serum YKL-40 levels in the three groups of patients: CCA, cholangiocarcinoma; ESLD, end-stage liver disease; and HCC, hepatocellular carcinoma. The boxes represent interquartile ranges, while the upper and lower ends of the whiskers denote the 5th and 95th percentiles of the data, respectively.